Bibliography

Found 921 results

2014

Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS [Internet]. 2014 ;28(11):1579-1591. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24752083

Adiga R, Ozdemir AY, Carides A, Wasilewski M, Yen W, Chitturi P, Ellis RJ, Langford D. Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count. Journal of NeuroVirology [Internet]. 2014 ;20(4):371-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24817145

Zenón F, Segarra AC, Gonzalez M, Meléndez LM. Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol. 2014 ;9(5):703-15.

Pulliam L. Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infection. Curr HIV Res. 2014 ;12(2):77-84.

Ferrara M, Umlauf A, Sanders C, Meyer JM, McCutchan JA, Duarte NA, Atkinson JH, Grant I, Ellis RJ. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Res. 2014 ;218(1-2):201-8.

Tatro ET, Soontornniyomkij B, Letendre S, Achim C. Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir. BMC Infect Dis. 2014 ;14:386.

Gutierrez J, Goldman JE, Honig L, Elkind MSV, Morgello S, Marshall RS. Determinants of cerebrovascular remodeling: Do large brain arteries accomodate stenosis?. Atherosclerosis [Internet]. 2014 ;235(2):371-379. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24929285

Dever SM, Costin BN, Xu R, El-Hage N, Balinang J, Samoshkin A, O'Brien MA, McRae M, Diatchenko L, Knapp PE, et al. Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals. AIDS. 2014 ;28(1):19-30.

Fellows RP, Byrd D, Morgello S. Effects of information processing speed on learning, memory, and executive functioning in people living with HIV/AIDS. J Clin Exp Neuropsychol. 2014 ;36(8):806-17.

Meulendyke KA, Ubaida-Mohien C, Drewes JL, Liao Z, Gama L, Witwer KW, Graham DR, M Zink C. Elevated brain monoamine oxidase activity in SIV- and HIV-associated neurological disease. J Infect Dis. 2014 ;210(6):904-12.

Desplats P, Dumaop W, Cronin P, Gianella S, Woods SPaul, Letendre S, Smith DM, Masliah E, Grant I. Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PLoS One. 2014 ;9(7):e102555.

Suh H-S, Lo Y, Choi N, Letendre S, Lee SC. Evidence of the innate antiviral and neuroprotective properties of progranulin. PLoS One. 2014 ;9(5):e98184.

Holder GE, McGary CM, Johnson EM, Zheng R, John VT, Sugimoto C, Kuroda MJ, Kim W-K. Expression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection. J Neuroimmune Pharmacol. 2014 ;9(5):716-26.

Kallianpur AR, Jia P, Ellis RJ, Zhao Z, Bloss C, Wen W, Marra CM, Hulgan T, Simpson DM, Morgello S, et al. Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy. PLoS One. 2014 ;9(8):e103123.

Thames AD, Maganpatay L, Martínez-Maza O, Singer EJ, Hinkin CH, Byrd D, Levine AJ. Genotype, CSF inflammation, and cognitive impairment among African Americans and European Americans with HIV. 2014 .

Yuan S-B, Shi Y, Chen J, Zhou X, Li G, Gelman B, Lisinicchia JG, Carlton SM, Ferguson MR, Tan A, et al. Gp120 in the pathogenesis of human immunodeficiency virus-associated pain. Ann Neurol. 2014 ;75(6):837-50.

Morgello S, Murray J, Van Der Elst S, Byrd D. HCV, but not HIV, is a risk factor for cerebral small vessel disease. Neurol Neuroimmunol Neuroinflamm. 2014 ;1(3):e27.

Gill AJ, Kovacsics CE, Cross SA, Vance PJ, Kolson LL, Jordan-Sciutto KL, Gelman B, Kolson DL. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014 ;124(10):4459-72.

Kumar A, Ownby RL, Fernandez F, Valdes-Sueiras M, Kumar M. HIV -1 in the CNS in Post-cART era: Impact of Infection on Serotonin Status in Different Regions of Post Mortem Human Brain. In: 12th ISNV Symposium. 12th ISNV Symposium. New York: J. NeuroVirology; 2014.

Soontornniyomkij V, Umlauf A, Chung SA, Cochran ML, Soontornniyomkij B, Gouaux B, Toperoff W, Moore D, Masliah E, Ellis RJ, et al. HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 ;28(9):1297-306.

Kumar A, Ownby RL, Fernandez JB, Valdes-Sueiras M, Kumar M. HIV-1 in the Post Mortem Brain Regions in the post-cART era: Impact of Infection on Serotonin Status in Different Regions of Post Mortem Human Brain. 2014 .

Keltner JR, Fennema-Notestine C, Vaida F, Wang D, Franklin D, Dworkin RH, Sanders C, McCutchan JA, Archibald SL, Miller DJ, et al. HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol. 2014 ;20(3):209-18.

Mocchetti I, Bachis A, Esposito G, Turner SR, Taraballi F, Tasciotti E, Paige M, Avdoshina V. Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration. Curr Trends Neurol. 2014 ;8:71-85.

Panos SE, Del Re AC, Thames AD, Patel SM, Castellon SA, Singer EJ, Hinkin CH. The impact of neurobehavioral features on medication adherence in HIV: evidence from longitudinal models. AIDS Care [Internet]. 2014 ;26(1):79-86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23756102

Mocchetti I, Bachis A, Campbell LA, Avdoshina V. Implementing Neuronal Plasticity in NeuroAIDS: the Experience of Brain-derived Neurotrophic Factor and other Neurotrophic Factors. Journal of Neuroimmune Pharmacology [Internet]. 2014 ;9(2):80-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23832285

Pages